Daily Derm Times: May 15, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Practice and Personal Planning: Tactics That Reduce Taxes and Protect Assets

Explore effective tax and asset protection strategies for dermatologists, including retirement plans and life insurance options for wealth management.

Risankizumab Effective in Difficult-to-Treat Psoriasis Areas

Discover the promising results of risankizumab for treating genital and scalp psoriasis, showcasing significant improvements in symptoms and quality of life.

Artax Biopharma's AX-158: A Novel Approach to T Cell-Driven Inflammation in Psoriasis

Scott Batty, MD, and Chris VanDeusen, PhD, provided insights on AX-158's phase 2a results, presented at the SID Annual Meeting.

Lurie Children’s Becomes First Treatment Center for Zevaskyn Gene Therapy in Patients with RDEB

ZEVASKYN, the first FDA-approved gene therapy for wounds in recessive dystrophic epidermolysis bullosa, is now available at Lurie Children's Hospital.

IL-23 and IL-17 Inhibitors Reduce Cardiovascular Outcomes in Statin-Treated Psoriasis Patients

Biologics significantly lower cardiovascular risks in psoriasis patients on statins, highlighting their dual benefits for skin and heart health.

New Guidance Aims to Improve Genital Psoriasis Treatment

New guidelines from the Genital Psoriasis Wellness Consortium highlight the significant impact of genital psoriasis on patients, emphasizing improved diagnosis and personalized treatment.